SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-274069
Filing Date
2023-11-09
Accepted
2023-11-09 07:41:00
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d280768d8k.htm   iXBRL 8-K 25195
2 EX-99.1 d280768dex991.htm EX-99.1 121840
6 GRAPHIC g280768g1109051806179.jpg GRAPHIC 3510
  Complete submission text file 0001193125-23-274069.txt   292643

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrca-20231109.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20231109_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20231109_pre.xml EX-101.PRE 11707
8 EXTRACTED XBRL INSTANCE DOCUMENT d280768d8k_htm.xml XML 3443
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 231390098
SIC: 2834 Pharmaceutical Preparations